1. Home
  2. WIX vs KRYS Comparison

WIX vs KRYS Comparison

Compare WIX & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wix.com Ltd.

WIX

Wix.com Ltd.

HOLD

Current Price

$97.34

Market Cap

7.6B

Sector

Technology

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$248.54

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WIX
KRYS
Founded
2006
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.3B
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
WIX
KRYS
Price
$97.34
$248.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
9
Target Price
$183.62
$226.56
AVG Volume (30 Days)
1.1M
285.6K
Earning Date
02-18-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
47.59
275.72
EPS
2.36
6.66
Revenue
$1,929,230,000.00
$373,164,000.00
Revenue This Year
$14.56
$36.14
Revenue Next Year
$14.23
$41.80
P/E Ratio
$42.43
$36.98
Revenue Growth
13.22
54.51
52 Week Low
$92.23
$122.80
52 Week High
$247.11
$265.92

Technical Indicators

Market Signals
Indicator
WIX
KRYS
Relative Strength Index (RSI) 33.25 62.15
Support Level $99.55 $245.68
Resistance Level $102.88 $257.95
Average True Range (ATR) 3.20 7.95
MACD 0.15 -1.56
Stochastic Oscillator 13.76 63.04

Price Performance

Historical Comparison
WIX
KRYS

About WIX Wix.com Ltd.

Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves, or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years has invested heavily and introduced its Wix Studio offering for partners, who are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: